14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
The French Competition Authority sanctions a grouping of road hauliers for customer allocation - O...
Read More >
Seyfarth Synopsis: A new decision in the Southern District of New York held that the N.Y. prohibitio...
Read More >
Effective January 6, 2020, companies who employ commercial motor vehicle drivers must register with ...
Read More >
he Supreme Court of Pennsylvania just revived the Paid Sick Days Act (PSDA), a 2015 ordinance that r...
Read More >
On August 6, 2019, the Fifth Circuit Court of Appeals ruled that the Equal Employment Opportunity Co...
Read More >
CONVERGE is in its 5th year of bringing together the world’s leading companies for 2 days of dynami...
Read More >